World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2893)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

HTML

2323

Tables (1-2)

162

Sum=2534

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

150

Sum=212

May 21, 2024 (publication date) through Jan 22, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Ninomiya Y, Yamamoto M, Kazuno A, Nabeshima K, Nishi T, Mori M. Immunotherapy for esophageal cancer: Where are we now and where can we go. World J Gastroenterol 2024; 30(19): 2496-2501 [PMID: 38817664 DOI: 10.3748/wjg.v30.i19.2496]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i19/2496.htm

Number	Citing Articles
1	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875 Abstract(232) \| Core Tip(235) \| Full Article(HTML)(498) \| Full Article with Cover (PDF)-639K(38) \| Audio-785K(6) \| Peer-Review Report-230K(23) \| Answering Reviewers-209K(28) \| Full Article (PDF)-410K(39) \| Full Article (XML)-117K(26) \| Times Cited (0) \| Total Visits (1565) \| Open
2	Sung Eun Kim, Kyoungwon Jung, Moo In Park. Immunotherapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma. Journal of Digestive Cancer Research 2024; 12(2): 72 doi: 10.52927/jdcr.2024.12.2.72
3	Qin Wang, Qing-Rong Li, Lei Xu, Zi-Chun Yuan, Xiao Liu, Mao-Ju Tang, Man Luo, Xiao-Wu Zhong, Qiang Ma, Xiao-Lan Guo. BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation. World Journal of Gastrointestinal Oncology 2025; 17(1): 99376 doi: 10.4251/wjgo.v17.i1.99376 Abstract(89) \| Core Tip(80) \| Full Article(HTML)(429) \| Full Article with Cover (PDF)-47861K(26) \| Audio-361K(4) \| Peer-Review Report-174K(16) \| Answering Reviewers-87K(15) \| Full Article (PDF)-47572K(32) \| Full Article (XML)-94K(15) \| Times Cited (0) \| Total Visits (1283) \| Open
4	Grigorios Christodoulidis, Sara Eirini Agko, Konstantinos Eleftherios Koumarelas, Marina Nektaria Kouliou, Dimitris Zacharoulis. Advancements and challenges in the treatment of esophageal cancer: A comprehensive review. World Journal of Clinical Oncology 2024; 15(12): 1463-1467 doi: 10.5306/wjco.v15.i12.1463 Abstract(144) \| Core Tip(151) \| Full Article(HTML)(601) \| Full Article with Cover (PDF)-611K(23) \| Audio-411K(3) \| Peer-Review Report-215K(14) \| Answering Reviewers-63K(16) \| Full Article (PDF)-372K(38) \| Full Article (XML)-52K(18) \| Times Cited (1) \| Total Visits (1191) \| Open
5	Yoshiaki Shoji, Kohei Kanamori, Kazuo Koyanagi, Tetsuya Otsuka, Rie Nakashima, Kohei Tajima, Mika Ogimi, Yamato Ninomiya, Miho Yamamoto, Akihito Kazuno, Takayuki Nishi, Masaki Mori. Conversion surgery for esophageal and esophagogastric junction cancer. International Journal of Clinical Oncology 2024; 29(12): 1777 doi: 10.1007/s10147-024-02639-4
6	Shilong Wu, Chenyang Xu, Huafeng Liu. Case report: Toxic epidermal necrolysis induced by tislelizumab in a patient with esophageal squamous cell carcinoma. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1522525
7	Xihao Xie, Hai Zhang, Haiquan He, Bomeng Wu, Ying Chen, Wanli Lin, Qingyi Feng, Qunqing Chen. Postoperative adjuvant immunotherapy for pathological stage II–IVa esophageal squamous cell carcinoma after radical surgery does not improve disease-free recurrence rates. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1517001
8	Jian-Zhou Tian, Li Zhang, Fu-Yong Lin, Ren-Jiao He, Wen-Rong Tian, Liu Yan, Guo-Xin Huang, Jin-Wei Ai, Bin Pei, De-Sheng Li. The efficacy and safety of PD-1 inhibitors combined with chemotherapy treatment for advanced esophageal cancer: a network meta-analysis. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1515263